| Company/Division name | Abingdon Health USA |
| Parent company | Abingdon Health |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 46 |
| Year reshoring announced: | 2026 |
| Offshore, work was done: | In-house |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 1.8 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Madison |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | rapid diagnostic tests |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives |
| Government Incentive dollar amount: | 370,000 |
